HUP0105310A3 - Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections - Google Patents

Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections

Info

Publication number
HUP0105310A3
HUP0105310A3 HU0105310A HUP0105310A HUP0105310A3 HU P0105310 A3 HUP0105310 A3 HU P0105310A3 HU 0105310 A HU0105310 A HU 0105310A HU P0105310 A HUP0105310 A HU P0105310A HU P0105310 A3 HUP0105310 A3 HU P0105310A3
Authority
HU
Hungary
Prior art keywords
prophylactic
infections
therapeutical treatment
phosphororganic compounds
phosphororganic
Prior art date
Application number
HU0105310A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of HUP0105310A2 publication Critical patent/HUP0105310A2/hu
Publication of HUP0105310A3 publication Critical patent/HUP0105310A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HU0105310A 1999-01-26 2000-01-25 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections HUP0105310A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19902924A DE19902924A1 (de) 1999-01-26 1999-01-26 Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen

Publications (2)

Publication Number Publication Date
HUP0105310A2 HUP0105310A2 (en) 2002-06-29
HUP0105310A3 true HUP0105310A3 (en) 2002-08-28

Family

ID=7895365

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105310A HUP0105310A3 (en) 1999-01-26 2000-01-25 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections

Country Status (14)

Country Link
EP (1) EP1146880A2 (no)
JP (1) JP2002535354A (no)
CN (1) CN1337881A (no)
AU (1) AU2439900A (no)
CA (1) CA2360661A1 (no)
CZ (1) CZ20012584A3 (no)
DE (1) DE19902924A1 (no)
HU (1) HUP0105310A3 (no)
IL (1) IL144115A0 (no)
NO (1) NO20013651L (no)
PL (1) PL349910A1 (no)
SK (1) SK10552001A3 (no)
TR (1) TR200102151T2 (no)
WO (1) WO2000044358A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842719B2 (en) * 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004085448A2 (en) * 2003-03-19 2004-10-07 Genzyme Corporation Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
JP2012521365A (ja) * 2009-03-20 2012-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 抗結核剤としてのプレニル化ビスホスホネート
CN104026151A (zh) * 2014-06-19 2014-09-10 南京麦思德餐饮管理有限公司 一种紫花苜蓿浸种剂
ES2970434T3 (es) 2014-09-12 2024-05-28 Union Therapeutics As Uso antibacteriano de salicilanilidas halogenadas
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
CN105403221B (zh) * 2015-10-27 2018-01-23 广东欧珀移动通信有限公司 一种导航路线的生成方法及移动终端
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170944A (en) * 1962-11-20 1965-02-23 Stauffer Chemical Co Haloacetonyl phosphonates and a method of preparing them
US3372209A (en) * 1964-08-24 1968-03-05 Monsanto Co Diphosphorus ester hydrocarbon diols
BE687874A (no) * 1965-10-06 1967-04-06
US3532774A (en) * 1966-09-29 1970-10-06 Monsanto Co Phosphinites,phosphine oxides and process for preparing
JPS4861259A (no) * 1971-12-02 1973-08-28
US4254114A (en) * 1979-01-02 1981-03-03 The Proctor & Gamble Company Control of pyrophosphate microorganisms with organophosphonates
JPS5655394A (en) * 1979-10-12 1981-05-15 Otsuka Chem Co Ltd 1,2-di alkoxycarbonylmethylamino ethylene-1,2-disulfonic acid phenyl ester derivative, its preparation, and herbicide containing said compound
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
US4820698A (en) * 1985-11-04 1989-04-11 The Procter & Gamble Company Antimicrobial agents and process for their manufacture
US5196409A (en) * 1989-08-20 1993-03-23 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
DE4336099A1 (de) * 1993-10-22 1995-04-27 Boehringer Mannheim Gmbh Neue 2.4-Diphosphonoglutarsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1996016629A2 (en) * 1994-11-18 1996-06-06 Amira Inc Phosphinic creatine compounds having antiviral activity
DE19532235A1 (de) * 1995-08-31 1997-03-06 Keppler Bernhard K Priv Doz Dr An Phosphonsäuren gekoppelte antibakteriell wirksame Verbindungen zur Therapie von Infektionen im Bereich des Knochens
GB9613637D0 (en) * 1996-06-28 1996-08-28 Agrevo Uk Ltd Fungicidal compositions
EP0944635A4 (en) * 1996-10-09 2000-07-05 Elizanor Biopharmaceuticals In THERAPEUTIC DIPHOSPHONATE COMPOUNDS

Also Published As

Publication number Publication date
WO2000044358A3 (de) 2001-03-15
EP1146880A2 (de) 2001-10-24
PL349910A1 (en) 2002-10-07
NO20013651L (no) 2001-09-18
AU2439900A (en) 2000-08-18
HUP0105310A2 (en) 2002-06-29
CA2360661A1 (en) 2000-08-03
WO2000044358A2 (de) 2000-08-03
SK10552001A3 (sk) 2001-12-03
DE19902924A1 (de) 2000-08-03
TR200102151T2 (tr) 2002-05-21
NO20013651D0 (no) 2001-07-25
CN1337881A (zh) 2002-02-27
CZ20012584A3 (cs) 2002-01-16
JP2002535354A (ja) 2002-10-22
IL144115A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
PL344535A1 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
EP1162994A4 (en) COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2798900A (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU3896900A (en) Treatment of pain
PL349910A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
NZ513686A (en) Treatment of trauma
IL133760A0 (en) Composition for the treatment of dandruff
GB9922752D0 (en) Medical devices and treatment and prophylaxis
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
AP2002002432A0 (en) Treatment of viral infections
AU2566201A (en) Compounds and methods for the treatment of pain
HUP0001891A2 (en) Medicament for the treatment of migraine
GB9906808D0 (en) Formulation for treatment of pain
GB9904252D0 (en) Composition for the treatment of pain
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
IL150208A0 (en) Compound and method for the treatment of pain
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU2420201A (en) Compounds and methods for the treatment of pain
IL145242A0 (en) Treatment of hiatial hernia
EP1165060A4 (en) PROCESSING OF BILARIAL CALCULATIONS
EP1158991A4 (en) ASTHMA TREATMENT